Guest Post: Does Charles Dickens still have great expectations? The Benefit Companies and some lost opportunities

Dr Marco Cristiano Petrassi, lawyer at SZA LLP expert in the area of corporate and commercial law, contributes to today’s guest post: "To do business by acting ethically and to be ethical without renouncing profit," this is the oxymoron of Benefit Companies. As a result of the spreading worldwide of the American movement B-Corps, the Benefit Companies … Continue reading Guest Post: Does Charles Dickens still have great expectations? The Benefit Companies and some lost opportunities

Guest Post: The UK’s voluntary Living Wage and its contribution to building a better economy and ethical business

Dr Andrea Werner, Senior Lecturer at the Department of Management Leadership & Organisations of the Middlesex University Business School, contributes to today’s guest post: In 2017, nearly 5 million people in the UK earned less than two-thirds than the poverty threshold of two-thirds of median hourly wage, an indication that despite low unemployment figures a significant proportion of the UK … Continue reading Guest Post: The UK’s voluntary Living Wage and its contribution to building a better economy and ethical business

Guest Post: Legal changes and paradigm shifts: what we need to get the benefits of whistleblowing

Greg Lawton, patient & medicines safety, data protection and healthcare policy consultant, contributes to today’s guest post. Greg, who worked for Boots between 2006 and 2015 and in his final role was part of the manpower planning team that assessed staffing levels in the company's pharmacies, resigned in 2015 after he took his concerns about … Continue reading Guest Post: Legal changes and paradigm shifts: what we need to get the benefits of whistleblowing

The alarming rise in the costs of drugs and the irresponsible behavior of pharmaceutical companies

Among all existing industries, the pharmaceutical sector is differentiated by the unique feature that it aims to fight diseases and conditions, thus directly contributing to the improvement of lives across the globe. With a focus on a basic human need such as health, pharmaceuticals have proven to be a highly profitable, prosperous, and ever-growing industry. … Continue reading The alarming rise in the costs of drugs and the irresponsible behavior of pharmaceutical companies

Silencing Human Rights and Environmental Defenders: The overuse of Strategic Lawsuits against Public Participation (SLAPP) by Corporations

Over the last few years, more and more corporations have used litigation as a tool to attack the credibility of human rights and environmental defenders. This phenomenon is part of what has been labelled, Strategic Litigation against Public Participation; more commonly referred to as SLAPP.  SLAPP is increasingly used by corporations against individuals, or civil … Continue reading Silencing Human Rights and Environmental Defenders: The overuse of Strategic Lawsuits against Public Participation (SLAPP) by Corporations

Guest Lecture: Mary Inman on Whistleblower Protection Law and Reward Programs (video)

It was a great privilege to have Mary Inman, who is a partner in Constantine Cannon's London Office specialized in representing whistleblowers worldwide, as a guest lecturer within my Corporate Governance and Globalization module at the University of East London. As I have recently mentioned in the article that focused on the Cambridge Analytica Scandal, … Continue reading Guest Lecture: Mary Inman on Whistleblower Protection Law and Reward Programs (video)

Debate on corporate corruption in the light of the 24-year sentence imposed to Park Guen-Hye in South Korea

Yesterday, I participated in an interview-debate on TRT World television, which is Turkey’s first international English-language news network with a global audience of over 260 million households. The debate was part of The Newsmakers, which is TRT World's flagship current affairs programme, and focused on the fight against corruption in the light of the 24-year sentence imposed … Continue reading Debate on corporate corruption in the light of the 24-year sentence imposed to Park Guen-Hye in South Korea